Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in atherosclerosis prevention

Maria M.Patarroyo Aponte, Gary S Francis

Research output: Contribution to journalArticle

19 Scopus citations

Abstract

Atherosclerosis is a highly complex biological process that has become the scourge of modern civilization. Endothelial dysfunction is the first step in the development of atherosclerosis. The renin-angiotensin-aldosterone system (RAAS) plays an important role in the development of endothelial dysfunction and atherosclerosis. Several studies have shown that in vitro blockade of the RAAS is associated with improvement in markers of endothelial dysfunction and inflammation. Many clinical trials have demonstrated a clear benefit of angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) manifested by a reduction of cardiovascular events. These findings suggest that ACEIs and ARBs can play an important role in prevention of atherosclerosis and in the delay of its progression. In this review we focus on the importance of RAAS blockade to prevent or delay progression of atherosclerosis and its impact on reduction of cardiovascular events.

Original languageEnglish (US)
Pages (from-to)433-442
Number of pages10
JournalCurrent Cardiology Reports
Volume14
Issue number4
DOIs
StatePublished - Aug 1 2012

Keywords

  • Angiotensin receptor blockers
  • Angiotensin-converting enzyme inhibitors
  • Atherosclerosis
  • Prevention
  • Renin-angiotensinaldosterone-system

Fingerprint Dive into the research topics of 'Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor antagonists in atherosclerosis prevention'. Together they form a unique fingerprint.

  • Cite this